A CBD toothpaste is set to hit the UK market after a trans-Atlantic agreement was struck.
Zelira Therapeutics has signed a deal with UK-based Health House International to distribute the SprinjeneCBD product.
Under the terms of the deal, a minimum of $250,000 worth of the product will be introduced into the British market thanks to the exclusive partnership.
The toothpaste is already available to customers in the US and the move bolsters Zelira’s efforts to break into a market with ‘significant growth opportunities’.
Health House, which is listed on the Australian Stock Exchange, are specialists at distributing medical cannabis products in the UK, Europe and Australia.
Zelira Therapeutics managing director, Dr Oludare Odumosu said: “Zelira took a very strategic position in the cannabinoid-based consumer product segment with the successful launch of our first SprinjeneCBD oral care toothpaste product in the US.
“Health House International has established distribution networks in emerging markets such as the UK, and will be a key channel as we continue to grow our global distribution footprint.
“Through distribution partners like Health House International, Zelira is able to reach larger market segments and accelerate the delivery of quality CBD oral care products globally.”
The deal was struck this week and can progress quickly as applications like toothpaste which are not ingested do not need to apply for validation under the novel foods process.
Tony Samios, Health House’s CEO for the UK and Europe, claimed the product may be able to fight common dental problems.
He said: “The Zelira CBD toothpaste brand manufactured by Springjene in the US, represents a unique product offering in Oral Healthcare, which adds to Health House’s existing range of cannabis products.
“It is made up of patented formulation of zinc, black seed oil and CBD which are thought to fight conditions like gingivitis and reduce gum inflammation, and to which the addition of CBD could make this even more effective.
“We are pleased to be able to bring this product into the UK market and distribute it to our range of clients. Test marketing to date suggests very strong interest in this product.”